Clinical Trial Update: Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluated adding Dexmedetomidine to Mannitol to attenuate increases in intracranial pressure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Hypertension

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Mannitol (mannitol)

Snippet

Sponsor: Cairo University | Conditions: Dexmedetomidine | Phase 2, Phase 3 | Status: COMPLETED